Fate therapeutics announces five presentations on off-the-shelf car t-cell product platform at asgct annual meeting

Updated clinical and preclinical data showcase ipsc-derived off-the-shelf car t-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer indications updated clinical and preclinical data showcase ipsc-derived off-the-shelf car t-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer indications
CAR Ratings Summary
CAR Quant Ranking